Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations.
2011
7070 Background: All patients at MSKCC with lung adenocarcinoma undergo reflex testing for EGFR and KRAS mutations at the time of surgical resection. KRAS mutations occurred in 19% of resected lung...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI